* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Museum to harvest rainwater soon
indiatimes.com
Apr 8, 2008
        

Rather than alarming heritage activists, the little furrows that have been dug up along the walls of the city museum will actually make them happy. ... The Chhatrapati Shivaji Maharaj Vastu Sangrahalaya, formerly the Prince of Wales Museum, has become the first heritage... [read full story]                    

Add Comment
View all news articles about*:
Abha Arabia Asir Indus Saudi
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

ImmunoCellular Therapeutics Announces Filing Of Patent Application For A Novel Cancer Stem Cell...

medicalnewstoday.com
4 mins ago 4 related
        

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine...

add comment

Biovail Comments On Filing Of Lawsuit

medicalnewstoday.com
4 mins ago
        

Biovail Corporation (NYSE, TSX: BVF) today announced that it has been notified that a proposed securities class action lawsuit has been filed in the U.S. District Court Southern District of New York against the Company, its...

add comment

Roche NimbleGen Launches 2.1 Million-Probe Arrays For The Detection Of Chromosomal Aberrations...

medicalnewstoday.com
4 mins ago 1 related
        

Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company's new 2.1...

add comment

Inspire Initiates Phase 1 Trial Of INS117548 For Glaucoma

medicalnewstoday.com
4 mins ago 3 related
        

Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced that it has initiated a Phase 1 clinical trial with INS117548 Ophthalmic Solution for the treatment of glaucoma. The placebo-controlled, dose-escalating trial is designed to...

add comment